deseq2 Search Results


deseq2  (RStudio)
90
RStudio deseq2
(A) A phase-contrast image of untreated H9 ESCs (left) and 48 hour ACTIVIN A treated H9 ESCs (right) cultured as previously described (See ). (B) FACS analysis of TRA-1-60 antigen (sc-21750, Santa Cruz Biotech) of the two cell types described in panel A using BD Fortessa Analyzer. The y-axis indicates the number of cells and the x-axis indicates the FITC signal (TRA-1-60, untreated H9 ESCs: 93.1% +/- 0.92 positive vs ACTIVIN A: 51.2% +/- 1.1 positive; N = 2, p = 0.0076). The quantitation was limited to live cells by first removing debris and dead cells. (C) Immunostaining of the endodermal marker CXCR4 on untreated and 48 hour ACTIVIN A treated H9 ESCs. Images were acquired using identical exposure conditions for untreated and treated cells. Scale bars, 100 μm. (D) A volcano plot is shown, which presents the significance of each genes change in expression (p-adjusted) as a function of its fold change. The clear circles with black outlines, mostly found at the top of the plot, represent the change in gene expression after 6 hours. The filled gray circles indicate the change in gene expression after 48 hours. Genes from endoderm (filled red circles), mesoderm (filled blue squares), ectoderm (filled green triangles), and pluripotency-markers (filled black diamonds) are indicated within the plot. (E-H) The fold change in expression after 48 hours of ACTIVIN A treatment is shown for endoderm (E), mesoderm (F), ectoderm (G), and pluripotency markers (H). Significance testing was performed within <t>DESeq2</t> using the Benjamini/Hochberg correction to generate the adjusted p-value (p-adjusted), which represents a false discovery rate (FDR) of 10% .
Deseq2, supplied by RStudio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/deseq2/deseq2/pmc04907514-178-4-6
Average 90 stars, based on 1 article reviews
deseq2 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
deseq2 rna  (Promega)
90
Promega deseq2 rna
(A) A phase-contrast image of untreated H9 ESCs (left) and 48 hour ACTIVIN A treated H9 ESCs (right) cultured as previously described (See ). (B) FACS analysis of TRA-1-60 antigen (sc-21750, Santa Cruz Biotech) of the two cell types described in panel A using BD Fortessa Analyzer. The y-axis indicates the number of cells and the x-axis indicates the FITC signal (TRA-1-60, untreated H9 ESCs: 93.1% +/- 0.92 positive vs ACTIVIN A: 51.2% +/- 1.1 positive; N = 2, p = 0.0076). The quantitation was limited to live cells by first removing debris and dead cells. (C) Immunostaining of the endodermal marker CXCR4 on untreated and 48 hour ACTIVIN A treated H9 ESCs. Images were acquired using identical exposure conditions for untreated and treated cells. Scale bars, 100 μm. (D) A volcano plot is shown, which presents the significance of each genes change in expression (p-adjusted) as a function of its fold change. The clear circles with black outlines, mostly found at the top of the plot, represent the change in gene expression after 6 hours. The filled gray circles indicate the change in gene expression after 48 hours. Genes from endoderm (filled red circles), mesoderm (filled blue squares), ectoderm (filled green triangles), and pluripotency-markers (filled black diamonds) are indicated within the plot. (E-H) The fold change in expression after 48 hours of ACTIVIN A treatment is shown for endoderm (E), mesoderm (F), ectoderm (G), and pluripotency markers (H). Significance testing was performed within <t>DESeq2</t> using the Benjamini/Hochberg correction to generate the adjusted p-value (p-adjusted), which represents a false discovery rate (FDR) of 10% .
Deseq2 Rna, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/deseq2/deseq2+rna/pm36009798-86-3-10
Average 90 stars, based on 1 article reviews
deseq2 rna - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
lexogen quantseq de 1.2  (Bluebee Inc)
90
Bluebee Inc lexogen quantseq de 1.2
(A) A phase-contrast image of untreated H9 ESCs (left) and 48 hour ACTIVIN A treated H9 ESCs (right) cultured as previously described (See ). (B) FACS analysis of TRA-1-60 antigen (sc-21750, Santa Cruz Biotech) of the two cell types described in panel A using BD Fortessa Analyzer. The y-axis indicates the number of cells and the x-axis indicates the FITC signal (TRA-1-60, untreated H9 ESCs: 93.1% +/- 0.92 positive vs ACTIVIN A: 51.2% +/- 1.1 positive; N = 2, p = 0.0076). The quantitation was limited to live cells by first removing debris and dead cells. (C) Immunostaining of the endodermal marker CXCR4 on untreated and 48 hour ACTIVIN A treated H9 ESCs. Images were acquired using identical exposure conditions for untreated and treated cells. Scale bars, 100 μm. (D) A volcano plot is shown, which presents the significance of each genes change in expression (p-adjusted) as a function of its fold change. The clear circles with black outlines, mostly found at the top of the plot, represent the change in gene expression after 6 hours. The filled gray circles indicate the change in gene expression after 48 hours. Genes from endoderm (filled red circles), mesoderm (filled blue squares), ectoderm (filled green triangles), and pluripotency-markers (filled black diamonds) are indicated within the plot. (E-H) The fold change in expression after 48 hours of ACTIVIN A treatment is shown for endoderm (E), mesoderm (F), ectoderm (G), and pluripotency markers (H). Significance testing was performed within <t>DESeq2</t> using the Benjamini/Hochberg correction to generate the adjusted p-value (p-adjusted), which represents a false discovery rate (FDR) of 10% .
Lexogen Quantseq De 1.2, supplied by Bluebee Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/deseq2/deseq2+application/pmc06813745-77-6-9
Average 90 stars, based on 1 article reviews
lexogen quantseq de 1.2 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
deseq2  (OmicSoft Corporation)
90
OmicSoft Corporation deseq2
(A) A phase-contrast image of untreated H9 ESCs (left) and 48 hour ACTIVIN A treated H9 ESCs (right) cultured as previously described (See ). (B) FACS analysis of TRA-1-60 antigen (sc-21750, Santa Cruz Biotech) of the two cell types described in panel A using BD Fortessa Analyzer. The y-axis indicates the number of cells and the x-axis indicates the FITC signal (TRA-1-60, untreated H9 ESCs: 93.1% +/- 0.92 positive vs ACTIVIN A: 51.2% +/- 1.1 positive; N = 2, p = 0.0076). The quantitation was limited to live cells by first removing debris and dead cells. (C) Immunostaining of the endodermal marker CXCR4 on untreated and 48 hour ACTIVIN A treated H9 ESCs. Images were acquired using identical exposure conditions for untreated and treated cells. Scale bars, 100 μm. (D) A volcano plot is shown, which presents the significance of each genes change in expression (p-adjusted) as a function of its fold change. The clear circles with black outlines, mostly found at the top of the plot, represent the change in gene expression after 6 hours. The filled gray circles indicate the change in gene expression after 48 hours. Genes from endoderm (filled red circles), mesoderm (filled blue squares), ectoderm (filled green triangles), and pluripotency-markers (filled black diamonds) are indicated within the plot. (E-H) The fold change in expression after 48 hours of ACTIVIN A treatment is shown for endoderm (E), mesoderm (F), ectoderm (G), and pluripotency markers (H). Significance testing was performed within <t>DESeq2</t> using the Benjamini/Hochberg correction to generate the adjusted p-value (p-adjusted), which represents a false discovery rate (FDR) of 10% .
Deseq2, supplied by OmicSoft Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/deseq2/deseq2+algorithm/pmc11608238-297-10-17
Average 90 stars, based on 1 article reviews
deseq2 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
deseq2 version 1.24  (GenXPro Inc)
90
GenXPro Inc deseq2 version 1.24
(A) A phase-contrast image of untreated H9 ESCs (left) and 48 hour ACTIVIN A treated H9 ESCs (right) cultured as previously described (See ). (B) FACS analysis of TRA-1-60 antigen (sc-21750, Santa Cruz Biotech) of the two cell types described in panel A using BD Fortessa Analyzer. The y-axis indicates the number of cells and the x-axis indicates the FITC signal (TRA-1-60, untreated H9 ESCs: 93.1% +/- 0.92 positive vs ACTIVIN A: 51.2% +/- 1.1 positive; N = 2, p = 0.0076). The quantitation was limited to live cells by first removing debris and dead cells. (C) Immunostaining of the endodermal marker CXCR4 on untreated and 48 hour ACTIVIN A treated H9 ESCs. Images were acquired using identical exposure conditions for untreated and treated cells. Scale bars, 100 μm. (D) A volcano plot is shown, which presents the significance of each genes change in expression (p-adjusted) as a function of its fold change. The clear circles with black outlines, mostly found at the top of the plot, represent the change in gene expression after 6 hours. The filled gray circles indicate the change in gene expression after 48 hours. Genes from endoderm (filled red circles), mesoderm (filled blue squares), ectoderm (filled green triangles), and pluripotency-markers (filled black diamonds) are indicated within the plot. (E-H) The fold change in expression after 48 hours of ACTIVIN A treatment is shown for endoderm (E), mesoderm (F), ectoderm (G), and pluripotency markers (H). Significance testing was performed within <t>DESeq2</t> using the Benjamini/Hochberg correction to generate the adjusted p-value (p-adjusted), which represents a false discovery rate (FDR) of 10% .
Deseq2 Version 1.24, supplied by GenXPro Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/deseq2/deseq2+version+1+24/pmc08333284-240-1-13
Average 90 stars, based on 1 article reviews
deseq2 version 1.24 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
deseq2  (Epigenomics ag)
90
Epigenomics ag deseq2
Major omics types and analysis tools.
Deseq2, supplied by Epigenomics ag, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/deseq2/deseq2/pmc11675490-10-15-0
Average 90 stars, based on 1 article reviews
deseq2 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
deseq2 v1.20.00  (SciCrunch Inc)
90
SciCrunch Inc deseq2 v1.20.00

Deseq2 V1.20.00, supplied by SciCrunch Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/deseq2/deseq2/pmc06856760-29-0-3
Average 90 stars, based on 1 article reviews
deseq2 v1.20.00 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
deseq 2 software package  (RStudio)
90
RStudio deseq 2 software package

Deseq 2 Software Package, supplied by RStudio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/deseq2/deseq+2+software+package/10__1097_slash_hc9__0000000000000360-87-15-20
Average 90 stars, based on 1 article reviews
deseq 2 software package - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
the deseq2 statistical method  (BioCampus Cologne)
90
BioCampus Cologne the deseq2 statistical method

The Deseq2 Statistical Method, supplied by BioCampus Cologne, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/deseq2/the+deseq2+statistical+method/bio_rxiv__2024__10__27__620509-60-7-12
Average 90 stars, based on 1 article reviews
the deseq2 statistical method - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
deseq2  (Shanghai LIDE Biotech Co Ltd)
90
Shanghai LIDE Biotech Co Ltd deseq2

Deseq2, supplied by Shanghai LIDE Biotech Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/deseq2/deseq2/pm39838379-24-18-8
Average 90 stars, based on 1 article reviews
deseq2 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
deseq2 pipeline  (HTG Molecular)
90
HTG Molecular deseq2 pipeline

Deseq2 Pipeline, supplied by HTG Molecular, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/deseq2/deseq2+package/10__1158_slash_1078___0432__ccr___20___4217-111-15-9
Average 90 stars, based on 1 article reviews
deseq2 pipeline - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
deseq2  (CLC Bio)
90
CLC Bio deseq2

Deseq2, supplied by CLC Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/deseq2/deseq2/pmc06949389-131-5-11
Average 90 stars, based on 1 article reviews
deseq2 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


(A) A phase-contrast image of untreated H9 ESCs (left) and 48 hour ACTIVIN A treated H9 ESCs (right) cultured as previously described (See ). (B) FACS analysis of TRA-1-60 antigen (sc-21750, Santa Cruz Biotech) of the two cell types described in panel A using BD Fortessa Analyzer. The y-axis indicates the number of cells and the x-axis indicates the FITC signal (TRA-1-60, untreated H9 ESCs: 93.1% +/- 0.92 positive vs ACTIVIN A: 51.2% +/- 1.1 positive; N = 2, p = 0.0076). The quantitation was limited to live cells by first removing debris and dead cells. (C) Immunostaining of the endodermal marker CXCR4 on untreated and 48 hour ACTIVIN A treated H9 ESCs. Images were acquired using identical exposure conditions for untreated and treated cells. Scale bars, 100 μm. (D) A volcano plot is shown, which presents the significance of each genes change in expression (p-adjusted) as a function of its fold change. The clear circles with black outlines, mostly found at the top of the plot, represent the change in gene expression after 6 hours. The filled gray circles indicate the change in gene expression after 48 hours. Genes from endoderm (filled red circles), mesoderm (filled blue squares), ectoderm (filled green triangles), and pluripotency-markers (filled black diamonds) are indicated within the plot. (E-H) The fold change in expression after 48 hours of ACTIVIN A treatment is shown for endoderm (E), mesoderm (F), ectoderm (G), and pluripotency markers (H). Significance testing was performed within DESeq2 using the Benjamini/Hochberg correction to generate the adjusted p-value (p-adjusted), which represents a false discovery rate (FDR) of 10% .

Journal: PLoS ONE

Article Title: The Regulation of rRNA Gene Transcription during Directed Differentiation of Human Embryonic Stem Cells

doi: 10.1371/journal.pone.0157276

Figure Lengend Snippet: (A) A phase-contrast image of untreated H9 ESCs (left) and 48 hour ACTIVIN A treated H9 ESCs (right) cultured as previously described (See ). (B) FACS analysis of TRA-1-60 antigen (sc-21750, Santa Cruz Biotech) of the two cell types described in panel A using BD Fortessa Analyzer. The y-axis indicates the number of cells and the x-axis indicates the FITC signal (TRA-1-60, untreated H9 ESCs: 93.1% +/- 0.92 positive vs ACTIVIN A: 51.2% +/- 1.1 positive; N = 2, p = 0.0076). The quantitation was limited to live cells by first removing debris and dead cells. (C) Immunostaining of the endodermal marker CXCR4 on untreated and 48 hour ACTIVIN A treated H9 ESCs. Images were acquired using identical exposure conditions for untreated and treated cells. Scale bars, 100 μm. (D) A volcano plot is shown, which presents the significance of each genes change in expression (p-adjusted) as a function of its fold change. The clear circles with black outlines, mostly found at the top of the plot, represent the change in gene expression after 6 hours. The filled gray circles indicate the change in gene expression after 48 hours. Genes from endoderm (filled red circles), mesoderm (filled blue squares), ectoderm (filled green triangles), and pluripotency-markers (filled black diamonds) are indicated within the plot. (E-H) The fold change in expression after 48 hours of ACTIVIN A treatment is shown for endoderm (E), mesoderm (F), ectoderm (G), and pluripotency markers (H). Significance testing was performed within DESeq2 using the Benjamini/Hochberg correction to generate the adjusted p-value (p-adjusted), which represents a false discovery rate (FDR) of 10% .

Article Snippet: This was input into DESeq2 within R studio for differential expression analysis, using a Benjamini/Hochberg corrected p-value cut-off of 0.1 (p-adjusted) [ ].

Techniques: Cell Culture, Quantitation Assay, Immunostaining, Marker, Expressing, Gene Expression

Major omics types and analysis tools.

Journal: Genes

Article Title: From Omics to Multi-Omics: A Review of Advantages and Tradeoffs

doi: 10.3390/genes15121551

Figure Lengend Snippet: Major omics types and analysis tools.

Article Snippet: Epigenomics , Analysis of DNA methylation and other epigenetic modifications , Bismark, MethylKit, MACS, HMMRATAC, Signac, DESeq2, edgeR.

Techniques: Sequencing, DNA Methylation Assay, Gene Expression, Glycoproteomics, RNA Sequencing, Imaging, Biomarker Discovery

Journal: Cell Reports

Article Title: Adult sox10 + Cardiomyocytes Contribute to Myocardial Regeneration in the Zebrafish

doi: 10.1016/j.celrep.2019.09.041

Figure Lengend Snippet:

Article Snippet: DESeq2 v1.20.00 , SciCrunch , SCR_015687.

Techniques: Recombinant, Software